Přejít k obsahu
Merck
Všechny fotografie(1)

Hlavní dokumenty

E-081

Supelco

Etizolam solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Přihlásitk zobrazení cen stanovených pro organizaci a smluvních cen


About This Item

Empirický vzorec (Hillův zápis):
C17H15ClN4S
Číslo CAS:
Molekulová hmotnost:
342.85
MDL number:
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.24

grade

certified reference material

Quality Level

form

liquid

feature

(Snap-N-Spike®)

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

drug control

Narcotic Licence Schedule B (Switzerland)

concentration

1.0 mg/mL in methanol

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

clinical testing

format

single component solution

storage temp.

−20°C

SMILES string

CCC1=CC2=C(S1)N3C(CN=C2C4=CC=CC=C4Cl)=NN=C3C

InChI

1S/C17H15ClN4S/c1-3-11-8-13-16(12-6-4-5-7-14(12)18)19-9-15-21-20-10(2)22(15)17(13)23-11/h4-8H,3,9H2,1-2H3

InChI key

VMZUTJCNQWMAGF-UHFFFAOYSA-N

General description

A certified solution standard for use in LC/MS or GC/MS benzodiazepine testing methods in clinical toxicology, urine drug testing, or forensic analysis. Etizolam, sold under brand names such as Etilaam, Etizola, or Depas, is a benzodiazepine analog used for the short-term treatment of insomnia, anxiety, or panic attacks. Etizolam is also sold on the designer drug market with cases of abuse noted in Europe and the US.

Application

  • A strategy for the detection of benzodiazepine drugs using low-resolution paper-spray mass spectrometry for harm reduction drug checking: This study explores the application of Etizolam in the development of low-cost, rapid mass spectrometric techniques for detecting benzodiazepines at harm reduction sites, emphasizing its utility in public health interventions (Miskulin et al., 2023).
  • Unexpected results found in larvae samples from two postmortem forensic cases: Incorporates Etizolam to elucidate drug metabolism in forensic toxicology, highlighting its relevance in the postmortem analysis and its impact on forensic investigations (Groth et al., 2022).
  • Rapid and accurate etizolam detection using surface-enhanced Raman spectroscopy for community drug checking: Demonstrates the use of Etizolam as a standard in developing cutting-edge, reliable spectroscopic methods for quick drug testing in community settings, thus advancing forensic and clinical toxicology (Gozdzialski et al., 2022).
  • Incorporation of five common hypnotics into hair after a single dose and application to a forensic case of drug facilitated crimes: This research utilizes Etizolam in studies focused on drug deposition in hair, providing crucial insights for the forensic analysis of drug-facilitated crimes (Sasaki et al., 2021).

Biochem/physiol Actions

Etizolam is a thienodiazepine anxiolytic and as compared to other benzodiazepines has lower dependence potential. It differs from other benzodiazepines in that its molecules possess a thiophene ring instead of benzene. It has anticonvulsant, sedative, anxiolytic, amnesic, hypnotic and muscle relaxant properties. It′s mode of action is through benzodiazepine receptor. It is used to treat insomnia, moderate depression and social anxiety disorder, and has occasionally been associated with blepharospasm and skin lesions.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

target_organs

Eyes

Storage Class

3 - Flammable liquids

wgk_germany

WGK 1

flash_point_f

49.5 °F

flash_point_c

9.7 °C


Seznamy omezení vyplývajících z předpisů

Seznamy omezení vyplývajících z předpisů jsou poskytovány zejména pro chemické produkty. Pro jiné než chemické produkty lze poskytovat pouze omezené informace. Žádný záznam znamená, že v seznamech není obsažena žádná ze součástí. Povinností uživatele je zajistit bezpečné a zákonné použití produktu.

EU REACH Annex XVII (Restriction List)

CAS No.

Vyberte jednu z posledních verzí:

Osvědčení o analýze (COA)

Lot/Batch Number

Je nám líto, ale pro tento produkt momentálně nemáme COA k dispozici online.

Potřebujete-li pomoc, obraťte se na Zákaznická podpora

Již tento produkt vlastníte?

Dokumenty související s produkty, které jste v minulosti zakoupili, byly za účelem usnadnění shromážděny ve vaší Knihovně dokumentů.

Navštívit knihovnu dokumentů

Zákazníci si také prohlíželi

Zenichiro Kato et al.
Pediatric emergency care, 23(7), 472-473 (2007-08-02)
Etizolam (ETZ) is an antidepressive thienodiazepine drug that is used worldwide. The most frequent adverse effects in adults are drowsiness and muscle weakness, and this can rarely cause paradoxical excitation; however, no information exists on intoxication in children. Furthermore, evidence
Akira Watanabe et al.
Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence, 39(5), 482-487 (2004-12-03)
Drug dependence is a social problem of over the world and resistant to medical intervention by psychiatrist as well as general clinicians. In Japan, methamphetamine dependence is one of the most critical social problems, but opioid dependence is relatively rare.
Takeshi Terao et al.
Progress in neuro-psychopharmacology & biological psychiatry, 31(1), 295-296 (2006-08-19)
A 65-year-old female patient with major depressive disorder suffered from clonus, shivering and impaired visual acuity after 20 mg/day of paroxetine administration. The symptoms were initially regarded as further manifestations of her somatic symptoms of depression, and paroxetine was increased
Maria Pia De Candia et al.
Clinical therapeutics, 31(12), 2851-2859 (2010-01-30)
Etizolam is an anxiolytic drug with a pharmacologic profile similar to that of the classic benzodiazepines. Neurochemical research suggests that etizolam may have selectivity for the subpopulation of Y-aminobutyric acid type A receptors associated with anxiety (ie, alpha1, beta2, gamma2).
Masahiro Hirase et al.
European journal of pharmacology, 597(1-3), 46-50 (2008-09-16)
The present study was performed to examine whether or not rebound insomnia is caused by an abrupt withdrawal of benzodiazepine hypnotics and tandospirone in rats. Etizolam and triazolam caused a significant shortening of sleep latency, increase in non-REM sleep time

Náš tým vědeckých pracovníků má zkušenosti ve všech oblastech výzkumu, včetně přírodních věd, materiálových věd, chemické syntézy, chromatografie, analytiky a mnoha dalších..

Obraťte se na technický servis.